RECRUITING

Benefits of Outdoor Walks in Reducing Depressive Symptoms

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to determine whether outdoor walking in different environments-urban or natural-can reduce depressive symptoms among college students. The study also tests whether providing prompts for active engagement during nature walks enhances the benefits compared to unstructured nature walks. Participants will be randomly assigned to one of three groups: (1) urban walk, (2) nature walk, or (3) active nature walk with guided interaction. Each participant will walk for 30 minutes, twice a week, for 3 weeks, complete questionnaires, and participate in interviews. Our primary outcome (PHQ-9) will be used to test the following two primary hypotheses: * Hypothesis 1: Participants in both nature walk conditions (combined) will show greater reductions in depressive symptoms (PHQ-9) than those in the urban walk group. * Hypothesis 2: Participants in the active nature walk will show greater reductions than those in the regular nature walk.

Official Title

Benefits of a Nature Walk vs. an Urban Walk in Reducing Depressive Symptoms: A Randomized Controlled Study Among College Students

Quick Facts

Study Start:2025-04-11
Study Completion:2025-12-27
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06989801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * College students in Seattle
  2. * Aged over 18.
  3. * Having depressive symptoms with self-rated Patient Health Questionnaire-9 (PHQ-9) scored higher than 5.
  4. * Normal or corrected-to-normal visual acuity.
  5. * No identified hearing impairment.
  6. * No history of neurological or mental disorders.
  1. * Receiving clinical psychiatric treatment or psychological counseling.
  2. * Failing in providing consent form.

Contacts and Locations

Study Contact

Xuanyi Wang
CONTACT
206 843 7335
wangxyi@uw.edu
Peter H Kahn, Ph.D.
CONTACT
206 616 9395
pkahn@u.washington.edu

Principal Investigator

Xuanyi Wang
PRINCIPAL_INVESTIGATOR
University of Washington

Study Locations (Sites)

Condon Hall
Seattle, Washington, 98105
United States
Merrill Hall
Seattle, Washington, 98105
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Xuanyi Wang, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-11
Study Completion Date2025-12-27

Study Record Updates

Study Start Date2025-04-11
Study Completion Date2025-12-27

Terms related to this study

Additional Relevant MeSH Terms

  • Depressive Symptoms